Welcome to the era of mindful medicine.
Psilera
At A
Glance
-
We have created and developed six separate serotonergic compound families.
-
Two patents have been issued from the USPTO covering over 1 million novel compounds.
-
The Psilera leadership team has over 100 years of combined experience in the biotech and pharmaceutical industries.
-
Our best-in-class proprietary compound library has coverage for over 1 million novel compounds.
-
Psilera’s co-founders bring over $1.5B in cumulative value created from prior start-ups.
Psilera is revolutionizing how small molecule drug discovery is done, giving rise to at-home therapy options for those suffering from neurological conditions.
Our neuroplastogenic pipeline offers a spectrum of solutions to meet the ever-evolving needs of patients.
UPCOMING EVENTS
UPCOMING EVENTS
April 19
Asheville, NC
The Pearl Institute’s Bicycle Day Symposium
The Pearl Institute to host their annual Bicycle Day Symposium, bringing together key thought leaders and researchers from the field of psychedelic science. Dr. Jackie von Salm joins the highly celebrated group of David Nichols, PhD, Hamilton Morris, Michael Cunningham, PhD, and Raymond Turpin, PhD on the panel The Chemistry of Consciousness: Psychedelic Science Past Future & Present.
April 24
Charlotte, NC
U.N.C. Dept. of Biological Sciences Seminar Series
Dr. Jackie von Salm has been nominated by the graduate students of the University of North Carolina Department of Biological Sciences to be the Distinguished Speaker in their seminar series. Her lecture, “Reimagining Psychoactive Natural Products as Treatments for CNS Disorders”, will illuminate the possibilities still out there in drug discovery for the next generation of innovators.
April 28 - 29
Boston, MA
Neuroscience Innovation Pharma Partnering Summit
Dr. Jackie von Salm will be speaking at the Neuroscience Innovation Pharma Partnering Summit in Boston. Focused on accelerating collaboration and partnership across neurology and psychiatry, the Summit allows key opinion leaders in the CNS space the opportunity to forge new connections. Joining her will be our EVP of Corporate Development Scott Rairigh. Together, they will continue to build Psilera’s partnering network as we move closer to the clinic. If you will be in Boston for the event and would like to connect, please message us at info@psilera.com.
June 10
Miami, FL
Oppenheimer’s CNS Day
Chris Witowski, PhD will be presenting on a panel alongside industry key opinion leaders and investors. More details to come. If you will be in Miami for the event and would like to connect, please message us at info@psilera.com.
Sept. 15 - 17
Boston MA
Neuropsychiatric Drug Development Summit
Chief Medical Officer Magali Haas, MD/PhD, to join Dr. Jackie von Salm at the 9th annual Neuropsychiatric Drug Development Summit. This event is a highlight of the fall conference schedule as the team gets to present and discuss our latest data with fellow innovators in the field. If you will be in Boston for the event and would like to connect, please message us at info@psilera.com.